EDITORIAL
Published on 15 Sep 2022
Editorial: Cholesterol and cancer drug resistance: Molecular, signaling, and therapeutic aspects
doi 10.3389/fgene.2022.994181
- 1,013 views
- 1 citation
- Frontiers in Genetics
- Human and Medical Genomics
- Research Topics
- Cholesterol and Cancer drug resistance: molecular, signaling and therapeutic aspects
Cholesterol and Cancer drug resistance: molecular, signaling and therapeutic aspects
5,647
Total downloads
21k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
MINI REVIEW
Published on 22 Mar 2022
Cholesterol-Lowering Phytochemicals: Targeting the Mevalonate Pathway for Anticancer Interventions
doi 10.3389/fgene.2022.841639
- 6,908 views
- 23 citations
REVIEW
Published on 19 Nov 2021
Mechanistic Insights Delineating the Role of Cholesterol in Epithelial Mesenchymal Transition and Drug Resistance in Cancer
doi 10.3389/fcell.2021.728325
- 3,021 views
- 20 citations
REVIEW
Published on 16 Sep 2021
Cholesterol-Lowering Drugs on Akt Signaling for Prevention of Tumorigenesis
doi 10.3389/fgene.2021.724149
- 4,359 views
- 14 citations
MINI REVIEW
Published on 14 Jun 2021
Targeting Growth Factor Signaling Pathways in Pancreatic Cancer: Towards Inhibiting Chemoresistance
doi 10.3389/fonc.2021.683788
- 4,065 views
- 13 citations
Published in
Frontiers in Genetics
- Human and Medical Genomics
Impact
- 21kTopic views
- 14kArticle views
- 5,647Article downloads